No Longer Available EXPANDED_ACCESS NCT04363034

Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program

Sponsor: University of Arkansas

Conditions COVID-19

Updated 7 times since 2020 Last updated: Mar 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04363034, this observational or N/A phase trial focuses on COVID-19 and remains ongoing. Sponsored by University of Arkansas, it has been updated 7 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

No Longer Available
Jul 2024 — Sep 2024 [monthly]

No Longer Available
Apr 2023 — Jul 2024 [monthly]

No Longer Available
Apr 2022 — Apr 2023 [monthly]

No Longer Available

Status: Temporarily Not Available → No Longer Available
May 2021 — Apr 2022 [monthly]

Temporarily Not Available

Status: Available → Temporarily Not Available

▶ Show 2 earlier versions

Jan 2021 — May 2021 [monthly]

Available
May 2020 — Jan 2021 [monthly]

Available

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Arkansas

Data source: University of Arkansas

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.